Marc Laporta, MD, develops international collaborative ventures  in the area of emergencies and disasters for the Americas.

As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Pedro Rosa-Neto is interested in the structural changes that occur in the brain as a result of neurodegenerative disease.

Duncan Pedersen studies how societies impact the mental health of their citizens. His work focuses on Latin America.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Mimi Israël is active in eating disorders, affective disorders, crisis intervention, emergency psychiatry and mental health care service organization.